Dr. Eric Velazquez named the Berliner Professor of Cardiology
Velazquez is globally recognized as an authority in heart failure, cardiovascular clinical trials, and cardiac imaging. (Source: Yale Science and Health News)
Source: Yale Science and Health News - August 13, 2018 Category: Universities & Medical Training Source Type: news

Aug 10, 2018 This Week in Cardiology Aug 10, 2018 This Week in Cardiology
AF screening, atrial flutter, palliative care in heart failure, and LDL-C lowering are discussed in this week's podcasttheheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 10, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Vaccinations in Decline at Heart Failure Hospitalization Vaccinations in Decline at Heart Failure Hospitalization
The drop in flu and pneumococcal vaccinations in such vulnerable patients in the analysis was worrisome; their cardioprotective efficacy was also questioned. But the data have caveats.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 9, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Will the Extravascular Method be a Game Changer for ICD Therapy?
Medtronic is aiming for a slightly different approach for implantable defibrillator therapy. Instead of using a transvenous approach the firm is looking at an extravascular method for ICD therapy. On Thursday, the Dublin-based company said it was beginning a pilot study of its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system, in which a lead is placed outside of the heart and veins to deliver lifesaving defibrillation and antitachycardia pacing therapy all in one system. EV ICD’s size is similar to transvenous ICDs. The first patient implant was performed at Christchurch Hospital in Ne...
Source: MDDI - August 9, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Heart Failure and Hypertension: Where do β-blockers Belong?
The author wants your opinion on the habitual titration of β-blockers in patients with comorbid HF who are not at BP goal.   (Source: ConsultantLive)
Source: ConsultantLive - August 9, 2018 Category: Internal Medicine Authors: Gregory W. Rutecki, MD Tags: Hypertension Source Type: news

'Tic'-tock
(Hiroshima University) Scientists in Japan have found a potential marker to identify which people with abnormally fast heartbeats are at high risk of developing heart failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2018 Category: International Medicine & Public Health Source Type: news

Estrogen may protect against depression after heart attack
(American Physiological Society) Estrogen may protect against heart failure-related depression by preventing the production of inflammation-causing chemicals in the brain. The study is published ahead of print in the American Journal of Physiology--Heart and Circulatory Physiology. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 9, 2018 Category: Biology Source Type: news

Epigenetic reprogramming of human hearts found in congestive heart failure
(University of Alabama at Birmingham) Congestive heart failure is a terminal disease that affects nearly 6 million Americans. Yet its management is limited to symptomatic treatments because the causal mechanisms of congestive heart failure are not known. Researchers have now described an underlying mechanism that reprograms the hearts of patients with ischemic cardiomyopathy, a process that differs from patients with other forms of heart failure. This points the way toward future personalized care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 9, 2018 Category: International Medicine & Public Health Source Type: news

FDA Expands Recall Of Common Blood Pressure Drug Over Cancer Concern
(CNN) — The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure. The FDA initially announced a valsartan recall in July after lab tests discovered that some drugs could have been tainted with a substance linked to higher risk of cancer. The drug had previously been recalled in 22 other countries. The expanded recall includes some drugs that contain valsartan and hydrochlorothisazide. Not all of the drugs containing valsartan were impacted. N-nitrosodimethylamine or NDMA, the i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 8, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Consumer Health News Local TV Recall Valsartan Source Type: news

FDA expands recall of blood pressure drug valsartan due to cancer concern
The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure. (Source: CNN.com - Health)
Source: CNN.com - Health - August 8, 2018 Category: Consumer Health News Source Type: news

Can manipulating gut microbes improve cardiac function in patients with heart failure?
(Wiley) A clinical study called the GutHeart Trial is poised to examine the potential relationship between the bacterial composition of the gut and inflammatory and metabolic pathways in the cardiovascular system (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 8, 2018 Category: International Medicine & Public Health Source Type: news

Women On Herceptin Need Regular Heart Checks
Women who take the chemotherapy drug trastuzumab (Herceptin) for HER2-positive breast cancer can be at higher risk for heart failure and should have their hearts monitored during treatment, new research finds. The complication is not common, and in many cases, the benefits of the chemotherapy still outweigh the risks. But regular checks should be a priority. (Source: WebMD Health)
Source: WebMD Health - August 7, 2018 Category: Consumer Health News Source Type: news

Women more likely to survive heart attack if treated by female doctor
Gender inequality in heart attack mortality because 'most physicians are male' Related items fromOnMedica Heart failure treatment based on ‘unrepresentative’ patients Migraine may be linked to heightened cardiovascular disease risk Erectile dysfunction increases cardiovascular risk Higher cancer risk from chronic diseases COPD patients at heightened risk of drug side effects linked to polypharmacy (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 7, 2018 Category: UK Health Source Type: news

Onyedika Ilonze Takes Heart at Baptist Health (Movers & Shakers)
Dr. Onyedika Ilonze has joined the cardiovascular team at Baptist Health Heart Failure & Transplant Institute in Little Rock. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - August 6, 2018 Category: American Health Source Type: news

Doxorubicin disrupts the immune system to cause heart toxicity
(University of Alabama at Birmingham) Doxorubicin is a chemotherapy drug used in ovarian, bladder, lung, thyroid and stomach cancers, but it carries a harmful side effect. The drug causes a dose-dependent heart toxicity that can lead to congestive heart failure. Researchers have found an important contributor to that heart pathology -- disruption of the metabolism that controls immune responses in the spleen and heart. This dysregulated immunometabolism impairs resolution of inflammation, and chronic, non-resolving inflammation leads to advanced heart failure. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 6, 2018 Category: Biology Source Type: news

Study: Prioritize cardiac monitoring for high-risk breast cancer patients
(American College of Cardiology) Overall, heart failure is an uncommon complication of breast cancer treatment; however, the risk is higher in patients treated with certain types of chemotherapy and lower in younger patients, according to a study in a special 'Imaging in Cardio-oncology' issue of JACC: Cardiovascular Imaging. Researchers concluded that cardiac monitoring should be a higher priority for high-risk patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: Even low air pollution may cause you serious heart problems
New research suggests that even low levels of air pollution may cause alterations in the heart that are akin to the early stages of heart failure. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 5, 2018 Category: Consumer Health News Tags: Heart Disease Source Type: news

AHA: Air Pollution Exposure Linked to Enlarged Hearts
FRIDAY, Aug. 3, 2018 (American Heart Association) -- Healthy people exposed to even low levels of air pollution over a handful of years developed enlarged heart chambers, a common precursor to heart failure, a new study indicates. While previous... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 3, 2018 Category: General Medicine Source Type: news

Air pollution linked to changes in heart structure
Study shows correlation between levels of exposure to fine particulate matter and chamber enlargement seen in early stages of heart failureAir pollution is linked to changes in the structure of the heart of the sort seen in early stages of heart failure, say researchers.The finding could help explain the increased number of deaths seen in areas with high levels of dirty air. For example, a report last year revealed that people in the UK are64 times more likely to die from the effect of air pollution than people living in Sweden. Such premature deaths can be linked toa number of causes includingrespiratory problems,stroke a...
Source: Guardian Unlimited Science - August 3, 2018 Category: Science Authors: Nicola Davis Tags: Air pollution Heart disease Environment Society Health Science Source Type: news

New UK research links even low levels of air pollution with serious changes in the heart
(British Heart Foundation) Research from the UK has found that people exposed to even low levels of air pollution have heart remodelling, similar to that seen in the early stages of heart failure. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2018 Category: International Medicine & Public Health Source Type: news

Noted UTA health care scholar elected American College of Cardiology Fellow
(University of Texas at Arlington) Mark Haykowsky, a University of Texas at Arlington nursing professor and leading expert in exercise physiology and heart failure rehabilitation, has been elected a fellow of the American College of Cardiology or ACC. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 3, 2018 Category: International Medicine & Public Health Source Type: news

Low levels of air pollution linked to changes in the heart
The changes are similar to those seen in the early stages of heart failure, experts say. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 3, 2018 Category: Consumer Health News Source Type: news

BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product
BETHESDA, Md.--BrainScope today announced its second consecutive nomination for the 2018 Annual Prix Galien USA Awards for “Best Medical Technology” product. Its flagship BrainScope One product is a multi-modal, comprehensive, handheld capability to help clinicians objectively and rapidly assess and triage head injured patients directly at the point of care. BrainScope’s innovative technology addresses a vast market need for the global epidemic of mild head injury, which impacts more people each year than stroke and heart failure combined. BrainScope One is the first FDA-cleared medica...
Source: JEMS: Journal of Emergency Medical Services News - August 2, 2018 Category: Emergency Medicine Authors: Brainscope Tags: Trauma Product Announcements News Industry News Source Type: news

BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product
BETHESDA, Md.--BrainScope today announced its second consecutive nomination for the 2018 Annual Prix Galien USA Awards for “Best Medical Technology” product. Its flagship BrainScope One product is a multi-modal, comprehensive, handheld capability to help clinicians objectively and rapidly assess and triage head injured patients directly at the point of care. BrainScope’s innovative technology addresses a vast market need for the global epidemic of mild head injury, which impacts more people each year than stroke and heart failure combined. BrainScope One is the first FDA-cleared medica...
Source: JEMS Patient Care - August 2, 2018 Category: Emergency Medicine Authors: Brainscope Tags: Trauma Product Announcements News Industry News Source Type: news

VisCardia heart failure implant study underway in Ukraine
VisCardia’s implantable VisOne diaphragm stimulator Novel heart failure device developer VisCardia, Inc. (Portland, Ore.) announced the first implant of the VisONE system for heart failure and the launch of the system’s heart failure pilot study in Ukraine. The VisONE implantable system delivers asymptomatic diaphragmatic stimulation (ADS) therapy to improve cardiac function. A surgeon laparoscopically implants a medical device equipped with electrodes to deliver electrical pulses to precise areas of the diaphragm. The electrically stimulated diaphragm applies transient intrathoracic pressur...
Source: Mass Device - August 2, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Source Type: news

AHA Introduces Heart Failure Certification Program
THURSDAY, Aug. 2, 2018 -- A hospital certification program offered by the American Heart Association (AHA) and The Joint Commission will be made available to hospitals seeking to implement exceptional efforts to foster better quality of care and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 2, 2018 Category: Pharmaceuticals Source Type: news

Protease Inhibitors May Worsen Outcomes for HIV & #43; Heart Failure
WEDNESDAY, Aug. 1, 2018 -- Ritonavir-boosted protease inhibitor (PI) therapy is associated with worse outcomes, including death, in patients with HIV and heart failure, according to a study published in the July 31 issue of the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 1, 2018 Category: Pharmaceuticals Source Type: news

A protein could be key to preserving heart function in Duchenne muscular dystrophy
(American Heart Association) The brain-derived neurotrophic factor protein, known to be vital for brain function, might hold the key for preserving heart function in children and young adults with Duchenne muscular dystrophy.Heart failure often kills Duchenne patients early in life and there is no effective treatment.Developing therapies designed to activate or supplement brain-derived neurotrophic factor could give new hope to patients at risk for Duchenne cardiomyopathy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 1, 2018 Category: International Medicine & Public Health Source Type: news

Drugs for heart failure are still under-prescribed, years after initial study
This study found that many people with heart failure do not receive the medications recommended for them under guidelines set by the American College of Cardiology, American Heart Association and Heart Failure Society of America. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 1, 2018 Category: International Medicine & Public Health Source Type: news

Medtronic Fires up SynchroMed II System for New Collaboration
Medtronic is partnering with United Therapeutics to launch a therapy that could help treat patients with pulmonary arterial hypertension (PAH). The Dublin-based company said it has received FDA approval for the Implantable System for Remodulin (ISR). In the collaboration, Medtronic’s SynchroMed II drug delivery system and cardiac catheter technologies were used to deliver the PAH medication Remodulin (treprostinil) Injection developed by United Therapeutics. PAH is a severely debilitating and progressive disease that causes high blood pressure in the pulmonary arteries, ultimately resulting in right-heart...
Source: MDDI - August 1, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

The Readmissions Conundrum: How (and What) Are We Doing?
It ’s been a good 6 years since the Centers for Medicare& Medicaid Services started wielding the stick called HRRP, the Hospital Readmissions Reduction Program, designed to encourage hospitals to improve discharge planning and reduce unnecessary acute care rehospitalizations. In 2012, the 30-day readmission rate for Medicare beneficiaries was around 19%, and it was thought that many of these readmissions were potentially avoidable. The penalties started at a maximum of 1% of a hospital ’s total Medicare A payments, and initially considered only the diagnoses of heart failure, acute myocardial infarction, an...
Source: Caring for the Ages - August 1, 2018 Category: Health Management Authors: Karl Steinberg Tags: on my mind Source Type: news

Too Few Patients With Heart Failure Get Palliative Care
Few patients with heart failure receive palliative care, although their condition often warrants it and evidence suggests it ’s helpful, a specialist in geriatrics and palliative medicine told an audience at the 2018 annual meeting of the American Geriatrics Society. (Source: Caring for the Ages)
Source: Caring for the Ages - August 1, 2018 Category: Health Management Authors: Randy Dotinga Source Type: news

Sacubitril/valsartan cost  effective for heart failure in Germany
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - August 1, 2018 Category: Drugs & Pharmacology Source Type: news

Colorado biotech company's shares soaring after getting good news from FDA
Shares in Arca Biopharma Inc. were soaring Tuesday after the Westminster biotech received good news from the U.S. Food and Drug Administration. Arca Biopharma (Nasdaq: ABIO) announced a "positive outcome of (an) end-of-phase 2 meeting with" the FDA regarding Gencaro treatment for atrial fibrillation (AF) patients with heart failure (HF). Arca Biopharma said it anticipates initiating a Phase 3 clinical trial "subject to securing additiona l financing through a strategic partnership and/or additional… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2018 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

Study: UVA heart failure program improves survival, reduces costs
(University of Virginia Health System) A University of Virginia Health System program that provides follow-up care for heart failure patients after they leave the hospital significantly improves survival and other outcomes while saving money, a new study finds. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 31, 2018 Category: International Medicine & Public Health Source Type: news

Drugs for heart failure are still under-prescribed, years after initial study
UCLADr. Gregg FonarowFINDINGSA UCLA-led study found that many people with heart failure do not receive the medications recommended for them under guidelines set by the American College of Cardiology, American Heart Association and Heart Failure Society of America.The research also found that doctors frequently prescribe medications at doses lower than those recommended by the guidelines, especially for older people, those with kidney disease, those with worsening symptoms or those who were recently hospitalized for heart failure. Further study is needed to determine why people in those four groups specifically were prescri...
Source: UCLA Newsroom: Health Sciences - July 31, 2018 Category: Universities & Medical Training Source Type: news

Report: Cook Medical warns of Brexit-imposed UK importation issues
Cook Medical is concerned that the Brexit may affect its ability to export products from Ireland to the UK after 2020, according to a new Irish Times report. The Bloomington, Ind.-based company, which employs 850 people in Limerick, Ireland, is looking to extend a transition agreement originally slated to end in 2020 until 2025 to allow it and other medtech companies to meet regulatory requirements in the UK and avoid product delays. Cook Medical didn’t state any concerns related to its employee base in Ireland or revenues, but did say that patients in the UK would likely be hurt if the deal wasn’t extende...
Source: Mass Device - July 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Cook Medical Source Type: news

The future of Abbott ’ s electrophysiology business
At DeviceTalks Minnesota 2018, medtech veteran Michael Pederson provided an inside look at the Abbott-St. Jude Medical merger and what’s ahead for Abbott’s cardiovascular technologies. Pederson tracked his career from a formative stint at HP to his current role as SVP of cardiac arrhythmias and heart failure at Abbott (NYSE:ABT). Check out his keynote address with DeviceTalks founder Brian Johnson. To learn more from the brightest minds in medtech, don’t miss DeviceTalks Boston on Oct. 8-10 The post The future of Abbott’s electrophysiology business appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - July 30, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Business/Financial News Cardiovascular DeviceTalks Q&A Wall Street Beat Abbott DeviceTalks Boston DeviceTalks Minnesota Source Type: news

Boston Scientific-backed gBeta accelerator picks 6 new startups
Minneapolis-based, Boston Scientific (NYSE:BSX) backed medtech accelerator Gener8tor announced six new entrants into its summer gBeta Medtech program last Wednesday, according to a MinneInno report. The gBeta accelerator, which is also supported by the Medical Alley Association, the University of Minnesota and the Mayo Clinic, will host the six companies in a free, seven-week long session. The program is designed to aid the startups in gaining insight on product development and customer traction and establishing metrics to seek selection into full-time accelerators or for finding seed investors, according to the repor...
Source: Mass Device - July 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development Boston Scientific Mayo Clinic Source Type: news

Is heart failure associated with risk of suicide? - Liu CH, Wang JH, Weng SC, Cheng YH, Yeh MK, Bai MY, Chang JC.
This study examined the relationship bet... (Source: SafetyLit)
Source: SafetyLit - July 30, 2018 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Medical News Today: Everything you need to know about bibasilar crackles
Bibasilar crackles are abnormal sounds from the base of the lungs, and they usually signal a problem with airflow. Some causes of bibasilar crackles include bronchitis, pulmonary fibrosis, pneumonia, and heart failure. In this article, we describe the sounds and symptoms in detail. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 27, 2018 Category: Consumer Health News Tags: Respiratory Source Type: news

Risk of Heart Failure Up in ALVSD Patients With Diabetes
FRIDAY, July 27, 2018 -- For patients with asymptomatic left ventricular systolic dysfunction (ALVSD), those with diabetes have increased risk of heart failure development and hospitalization, according to a study published in the June issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 27, 2018 Category: Pharmaceuticals Source Type: news

Heart Failure Guidelines: Introduction to the New Agents Heart Failure Guidelines: Introduction to the New Agents
Review updated guidelines for the management of heart failure that have been revised to include the two novel pharmacologic agents sacubitril/valsartan and ivabradine.U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Protease Inhibitors in Patients With HIV, HF May Up CV Mortality Protease Inhibitors in Patients With HIV, HF May Up CV Mortality
Readmission for heart-failure decompensation and cardiovascular death are more likely for patients with HIV on antiretrovirals who are also taking protease inhibitors, suggests a single-center study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 26, 2018 Category: Cardiology Tags: Cardiology News Source Type: news

HIV Increases Heart Failure Risk
(MedPage Today) -- Study adds to evidence but mechanism remains unclear (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 26, 2018 Category: Cardiology Source Type: news

Abiomed shares down despite Street-beating FY2019 Q1, Indian Impella approval
Shares in Abiomed (NSDQ:ABMD) have fallen today despite the medical device maker posting earnings that beat expectations by Wall Street for its fiscal year 2019 first quarter and announcing approval of its Impella heart pump in India. The Danvers, Mass.-based company posted profits of $90.1 million, or $1.95 per share, on sales of $180 million for the three months ended June 30, seeing profits grow 141% while sales grew 35.9% compared with the same period during the previous year. Earnings per share were well ahead of the 82¢ consensus on Wall Street, where analysts expected to see sales of $173.2 million, w...
Source: Mass Device - July 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiac Assist Devices Cardiovascular MassDevice Earnings Roundup Regulatory/Compliance Wall Street Beat Abiomed Source Type: news

This engineered heart ventricle helps with studying arrhythmia and cardiomyopathy
[Luke MacQueen and Michael Rosnach/Harvard University]While engineered heart tissues can replicate muscle contraction and electrical activity in a dish, many aspects of heart disease can only adequately be captured in 3D. In a report published online yesterday by Nature Biomedical Engineering, researchers describe a scale model of a heart ventricle, built to replicate the chamber’s architecture, physiology and contractions. Cardiac researchers at Boston Children’s Hospital think it could help them find treatments for congenital heart diseases. Building a 3D engineered heart ventricle Collaborators from the Harv...
Source: Mass Device - July 26, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog Vector Blog Source Type: news

ViewRay picks up ex-Spectranetics CEO Drake, COO Matin | Personnel Moves – July 25, 2018
ViewRay (NSDQ:VRAY) said yesterday it tapped former Spectranetics head Scott Drake as its new chief executive officer and former Spectranetics COO Shar Matin as its new COO. Before joining ViewRay, Drake served as CEO and prez of Spectranetics, which was acquired by Royal Philips (NYSE:PHG) in a deal that closed last August. Drake also serves as board chair for AtriCure and JustRight Surgical. Newly appointed COO Matin also worked for Spectranetics, starting in 2007, and holding the COO position from 2014 until it was acquired by Philips. “I am excited to join the ViewRay team as we drive growth and in...
Source: Mass Device - July 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News avitamedical Bonesupport Clinical Innovations google intentsolutions ohiomedical Olympus personnel-moves Procyrion royalphilips Spectranetics Corp. ViewRay Inc. Source Type: news

Adhesive respiratory monitor detects breathing problems early
[Image from Exspiron]Children can be at risk for compromised breathing after surgery or from conditions like asthma, congestive heart failure or sleep apnea. Opioid therapy and sedation for medical procedures can also depress breathing. Unless a child is sick enough to have a breathing tube, respiratory problems can be difficult to detect early. Yet early detection can mean the difference between life and death. “There is currently no real-time objective measure,” says Viviane Nasr, MD, an anesthesiologist with Boston Children’s Hospital’s Division of Cardiac Anesthesia. “Instead, respiratory ...
Source: Mass Device - July 25, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog Vector Blog Source Type: news

Houston medical device startup hires former Abbott exec as CEO
Houston-based Procyrion Inc., which is developing a catheter-deployed micropump to manage chronic heart failure, has hired a new president and CEO, effective immediately.   The board of directors selected Dr. Eric Fain to fill the roles and “accelerate the progression of product development leading to human clinical trials and commercialization” of the heart pump technology, called Aortix, according to a July 23 press release. Previous CEO Benjamin Hertzog rema in with Procyrion in a different… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 24, 2018 Category: Pharmaceuticals Authors: Olivia Pulsinelli Source Type: news